Lenskart Solutions Limited has informed the Exchange about the Monitoring Agency Report for the quarter ended June 30, 2026

Lenskart Solutions Limited (Earlier known as Lenskart Solutions Private Limited) Corporate Office: Ground Floor, Vipul Tech Square, Golf Course Road, Sector- 43, Gurugram, Haryana 122009 Date: August 13, 2026 National Stock Exchange of India Limited BSE Limited The Listing Department, Department of Corporate Services, Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Fort, Mumbai - 400 051 Mumbai - 400 001 Scrip Symbol: LENSKART S c r i p C o d e : 5 4 4600 Sub.: Disclosure under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Monitoring Agency Report for the quarter ended June 30, 2026 Dear Sir/ Ma’am, Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41 and other applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, we hereby enclose the Monitoring Agency Report dated August 13, 2026, issued by CARE Ratings Limited, the Monitoring Agency, in respect of the utilization of proceeds of the Company’s Initial Public Offer for the quarter ended June 30, 2026, as reviewed and approved by the Audit Committee of the Company in its meeting held on August, 11, 2026. Kindly take the same on record. The aforesaid details will also be hosted on the Company's website viz. https://www.lenskart.com/corporate/investorrelations. Thanking you, Yours Sincerely, For Lenskart Solutions Limited (Formerly known as Lenskart Solutions Private Limited) Ashish Kumar Srivastava Company Secretary and Chief Compliance Officer Membership No.: F5325 Place: Gurugram Regd. Office: Plot No. 151, Okhla Industrial Estate, Phase III, New Delhi 110020 Website: www.lenskart.com, Email: compliance.officer@lenskart.com, Phone No: 0124 – 4293191 CIN — L33100DL2008PLC178355 No. CARE/NRO/GEN/2026-27/1108 The Board of Directors Lenskart Solutions Limited Ground Floor, Vipul Tech Square, Golf Course Road Sector 43, DLF QE, Gurugram 122 009, Haryana, India August 13, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the IPO of Lenskart Solutions Limited (“the Company”) We write in our capacity of Monitoring Agency for the IPO for the amount aggregating to Rs. 2,150 crore of the Company and refer to our duties cast under 32(7) of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated October 14, 2025. Request you to kindly take the same on records. Thanking you, Yours faithfully, Sahil Goyal Associate Director Sahil.goyal@careedge.in Report of the Monitoring Agency Name of the issuer: Lenskart Solutions Ltd For quarter ended: June 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: NA (b) Range of Deviation: NA Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Sahil Goyal Designation of Authorized person/Signing Authority: Associate Director 1) Issuer Details: Name of the issuer : Lenskart Solutions Ltd Name of the promoter : Peyush Bansal, Neha Bansal, Amit Chaudhary and Sumeet Kapahi Industry/sector to which it belongs : Eyewear Retail Industry 2) Issue Details Issue Period : October 31, 2025 to November 4, 2025 Type of issue (public/rights) : Public Type of specified securities : Equity shares IPO Grading, if any : Not Applicable Issue size (in crore) : Rs. 2150.00 crore* *This MA Report pertains to the fresh issue component of the IPO amounting to Rs. 2150.00 crore. Particulars Remarks Total shares issued and subscribed as part of IPO (181,063,669 equity shares) 7,278.02 - Offer for sale 5,128.02 - Gross proceeds of the Fresh Issue 2,150.00 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Comments of the Source of information / certifications considered by Comments of the Particulars Reply Board of Monitoring Agency for preparation of report Monitoring Agency Directors During the quarter ended June 30, No comments 2026, the company has utilized Rs. Prospectus dated November 04, 2025, CA Certificate*, 186.71 crore towards the objects of Whether all utilization is as per the disclosures in the Yes Management utilisation Certificate, Bank statements, the issue out of the total issue Offer Document? FDRs and Sample Invoices proceeds of Rs. 2150 crore in line with the Prospectus. Note 1 Whether shareholder approval has been obtained in Prospectus dated November 04, 2025, CA Certificate*, No comments case of material deviations# from expenditures Management utilisation Certificate, Bank statements, Not Applicable Applicable disclosed in the Offer Document? FDRs and Sample Invoices Whether the means of finance for the disclosed objects Prospectus dated November 04, 2025, CA Certificate*, No comments No Nil of the issue have changed? Management utilisation Certificate, Bank statements, Comments of the Source of information / certifications considered by Comments of the Particulars Reply Board of Monitoring Agency for preparation of report Monitoring Agency Directors FDRs and Sample Invoices Prospectus dated November 04, 2025, CA Certificate*, No comments Is there any major deviation observed over the earlier No major deviation observed over the No Management utilisation Certificate, Bank statements, monitoring agency reports? last monitoring agency report FDRs and Sample Invoices Prospectus dated November 04, 2025, CA Certificate*, No comments Whether all Government/statutory approvals related to NA Management utilisation Certificate, Bank statements, Nil the object(s) have been obtained? FDRs and Sample Invoices Prospectus dated November 04, 2025, CA Certificate*, No comments Whether all arrangements pertain [Showing first 8,000 characters — download PDF for full document]